Prevalence and Disease Association of Human Parvovirus B19 in Iran: A Systematic Review

References

• Ozawa K , AyubJ, HaoY, KurtzmanG, ShimadaT, YoungN. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol., 61(8), 2395–2406 (1987).
   PubMed Web of Science ®Google Scholar
• Zadsar M , AghakhaniA, BanifazlMet al. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors. J. Med. Virol., 90(8), 1318–1322 (2018).
   PubMed Web of Science ®Google Scholar
• Azadmanesh K , MohrazM, KazemimaneshMet al. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV. J. Med. Virol., 87(7), 1124–1129 (2015).
   PubMed Web of Science ®Google Scholar
• Sharif A , AghakhaniA, VelayatiAAet al. Frequency and genotype of human parvovirus B19 among iranian hemodialysis and peritoneal dialysis patients. Intervirology, 59(3), 179–185 (2016).
   PubMed Web of Science ®Google Scholar
• Arabzadeh SA , AlizadehF, TavakoliAet al. Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran. Blood Res., 52(1), 50–54 (2017).
   PubMedGoogle Scholar
• Daly P , CorcoranA, MahonB, DoyleS. High-sensitivity PCR detection of parvovirus B19 in plasma. J. Clin. Microbiol., 40(6), 1958–1962 (2002).
   PubMed Web of Science ®Google Scholar
• Nayeri UA , BahtiyarMO. Parvovirus B19 infection during pregnancy. In: Obstetric Imaging: Fetal Diagnosis and Care (2nd Edition). Elsevier, Amsterdam, The Netherlands, 685–688 (2018).
   Google Scholar
• Crane J , MundleW, BoucoiranIet al. Parvovirus B19 infection in pregnancy. J. Obstet. Gynaecol. Can., 36(12), 1107–1116 (2014).
   PubMedGoogle Scholar
• Bosman A , WallingaJ, KroesA. Fifth disease every four years: parvovirus B19. Infectieziekten Bull., 13, 215–219 (2002).
   Google Scholar
• Heegaard ED , BrownKE. Human parvovirus B19. Clin. Microbiol. Rev., 15(3), 485–505 (2002).
   PubMed Web of Science ®Google Scholar
• Jordan J , ButchkoA. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 cytodeath antibody. Placenta, 23(7), 547–553 (2002).
   PubMed Web of Science ®Google Scholar
• Norja P , HokynarK, AaltonenL-Met al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc. Natl Acad. Sci. USA, 103(19), 7450–7453 (2006).
   PubMed Web of Science ®Google Scholar
• Maple PA , HedmanL, DhanilallPet al. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. J. Clin. Microbiol., 52(3), 947–956 (2014).
   PubMed Web of Science ®Google Scholar
• Ziyaeyan M , PourabbasB, AlborziA, MardanehJ. Prevalence of antibody to human parvovirus B19 in pre-school age/young adult individuals in Shiraz, Iran. Pak. J. Biol. Sci., 10(10), 1763–1765 (2007).
   PubMedGoogle Scholar
• Salimi V , GouyaMM, EsteghamatiARet al. Seroepidemiology of human parvovirus B19 in 5–25 year old age people in Iran. Iran. J. Public Health, 37(4), 19–25 (2008).
   Web of Science ®Google Scholar
• Rezaei F , SarshariB, GhavamiNet al. Prevalence and genotypic characterization of human parvovirus B19 in children with measles- and rubella-like illness in Iran. J. Med. Virol., 88(6), 947–953 (2016).
   PubMed Web of Science ®Google Scholar
• Aghakhani A , MohrazM, AzadmaneshKet al. No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up. Arch. Virol., 161(5), 1183–1187 (2016).
   PubMed Web of Science ®Google Scholar
• Abdollahi A , ShoarS, SheikhbahaeiS, MahdavianiB, RasoulinejadM. Status of immunity against PVB19 in HIV-infected patients according to CD4+ cell count, and antiretroviral therapy regimen groups. Niger. Med. J., 55(1), 20–23 (2014).
   PubMedGoogle Scholar
• Shabani Z , EsghaeiM, KeyvaniHet al. Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med. J. Islam. Repub. Iran, 29, 197 (2015).
   PubMedGoogle Scholar
• Rahbar N , Vali ZadehS, GhorbaniR, KheradmandP. Prevalence of parvovirus B19 specific antibody in pregnant women with spontaneous abortion. Acta Med. Iran., 53(3), 168–172 (2015).
   PubMedGoogle Scholar
• Khameneh ZR , HanifianH, BarzegariR, SepehrvandN. Human parvovirus B19 in Iranian pregnant women: a serologic survey. Indian J. Pathol. Microbiol., 57(3), 442–444 (2014).
   PubMed Web of Science ®Google Scholar
• Shahsiah R , MonajemzadehM, HoseinzadehHet al. Parvovirus B19 infection frequency in placenta of fetal loss cases in children medical center, Tehran, Iran. Iran. J. Pathol., 6(4), 202–207 (2011).
   Google Scholar
• Borna S , MirzaieF, Hanthoush-ZadehS, KhazardoostS, Rahimi-SharbafF. Middle cerebral artery peak systolic velocity and ductus venosus velocity in the investigation of nonimmune hydrops. J. Clin. Ultrasound, 37(7), 385–388 (2009).
   PubMed Web of Science ®Google Scholar
• Keikha F , Miri-MoghaddamE, Sharifi-MoodB. Prevalence of parvovirus B19 infection in successful and unsuccessful pregnancy in Zahedan, southeast of Iran. J. Med. Sci., 6(3), 495–497 (2006).
   Google Scholar
• Ziyaeyan M , RasouliM, AlborziA. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran. Jpn J. Infect. Dis., 58(2), 95–97 (2005).
   PubMed Web of Science ®Google Scholar
• Ardalan MR , ShojaMM, TubbsRS, JayneD. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis. Exp. Clin. Transplant., 6(2), 137–143 (2008).
   PubMed Web of Science ®Google Scholar
• Ardalan MR , ShojaMM, TubbsRS, EsmailiH, KeyvaniH. Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection. Am. J. Transplant., 8(6), 1340–1344 (2008).
   PubMed Web of Science ®Google Scholar
• Khameneh ZR , SepehrvandN, SohrabiV, GhasemzadehN. The seroprevalence of parvovirus B19 among kidney transplant recipients: a single-center study. Saudi J. Kidney Dis. Transplant., 25(1), 16–21 (2014).
   PubMedGoogle Scholar
• Nikoozad R , MahzouniehMR, GhoraniMR. Detection of parvovirus B19 infection in Thalasemic patients in Isfahan Province, Iran. Jundishapur J. Microbiol., 8(11), e26590 (2015).
   PubMed Web of Science ®Google Scholar
• Alavi SM , ArabiNM, YazdiMKM, ArzanianMTM, ZohrehbandianFM. Hereditary spherocytosis unmasked by human parvovirus B19 induced aplastic crisis in a family. Iran. J. Med. Sci., 40(5), 461–464 (2015).
   PubMedGoogle Scholar
• Mohammadi B , YaghobiR, DehghaniM, BehzadBehbahani A. The molecular prevalence of viral infections in transplant candidates with bone marrow suppression, shiraz, southern iran, 2010. Int. J. Organ Transplant. Med., 4(2), 87–94 (2013).
   PubMedGoogle Scholar
• Habibagahi MP , HabibagahiZM, SaidmardaniSMM, SadeghianFM. No definite association between human parvovirus B19 infection and behcet disease. Iran. J. Med. Sci., 40(6), 493–500 (2015).
   PubMedGoogle Scholar
• Irschick EU , PhilippS, ShahramFet al. Investigation of bacterial and viral agents and immune status in Behcet’s disease patients from Iran. Int. J. Rheum. Dis., 14(3), 298–310 (2011).
   PubMed Web of Science ®Google Scholar
• Shooshtari MM , ForoghiMN, HamkarR. High prevalence of parvovirus B19 IgG antibody among hemophilia patients in center for special diseases, Shiraz, Iran. Iran. J. Public Health, 34(1), 51–54 (2005).
   Google Scholar
• Karami A , HoseiniSL, RamazaniA, EmadiP, GholamiH, HoseiniSM. Prevalence of parvovirus B19 infection by serology and PCR in pregnant women referring to obstetrics and gynecology clinic. J. Natl Med. Assoc. (pii:S0027-9684(18)30411-52019) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Tavakoli A , MonavariSH, MollaeiHet al. Frequency of human parvovirus B19 among patients with respiratory infection in Iran. Med. J. Islam. Repub. Iran, 32, 38 (2018).
   PubMedGoogle Scholar
• Javanmard D , ZiaeeM, GhaffariHet al. Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia. Blood Res., 52(4), 311–315 (2017).
   PubMedGoogle Scholar
• Habibzadeh S , Peeri-DoghahehH, Mohammad-ShahiJ, MobiniE, ShahbazzadeganS. The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013. Iran. J. Microbiol., 8(3), 214–218 (2016).
   PubMed Web of Science ®Google Scholar
• Nunoue T , KusuharaK, HaraT. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr. Infect. Dis. J., 21(12), 1133–1136 (2002).
   PubMed Web of Science ®Google Scholar
• De Haan TR , OepkesD, BeersmaMF, WaltherFJ. Aetiology, diagnosis and treatment of hydrops foetalis. Curr. Pediatr. Rev., 1(1), 63–72 (2005).
   Google Scholar
• Enders M , WeidnerA, ZoellnerI, SearleK, EndersG. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat. Diagn., 24(7), 513–518 (2004).
   PubMed Web of Science ®Google Scholar
• Servey JT , ReamyBV, HodgeJ. Clinical presentations of parvovirus B19 infection. Am. Fam. Physician, 75(3), 373–376 (2007).
   PubMed Web of Science ®Google Scholar
• Khameneh ZR , SepehrvandN, MasudiS, Taghizade-AfshariA. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp. Clin. Transplant., 8(2), 146–149 (2010).
   PubMed Web of Science ®Google Scholar
• Kerr JR . A review of blood diseases and cytopenias associated with human parvovirus B19 infection. Rev. Med. Virol., 25(4), 224–240 (2015).
   PubMed Web of Science ®Google Scholar
• Dijkmans AC , DeJong EP, DijkmansBAet al. Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications. Curr. Opin. Obstet. Gynecol., 24(2), 95–101 (2012).
   PubMed Web of Science ®Google Scholar
• Jones L , ErdmanD, AndersonL. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection. J. Infect. Dis., 180(2), 500–504 (1999).
   PubMed Web of Science ®Google Scholar
• Magro CM , WusirikaR, FrambachGE, NuovoGJ, FerriC, RossP. Autoimmune-like pulmonary disease in association with parvovirus B19: a clinical, morphologic, and molecular study of 12 cases. Appl. Immunohistochem. Mol. Morphol., 14(2), 208–216 (2006).
   PubMedGoogle Scholar
• Khameneh ZR , SepehrvandN, Taghizadeh-AfshariA, MotazakkerM, GhafariA, MasudiS. Seroprevalence of herpes simplex virus-2 in kidney transplant recipients: a single-center experience. Iran. J. Kidney Dis., 4(2), 158 (2010).
   PubMed Web of Science ®Google Scholar
• Drago F , CiccareseG, BroccoloF, JavorS, ParodiA. Atypical exanthems associated with parvovirus B19 (B19V) infection in children and adults. J. Med. Virol., 87(11), 1981–1984 (2015).
   PubMed Web of Science ®Google Scholar
• Hankins JS , PenkertRR, LavoieP, TangL, SunY, HurwitzJL. Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era. Exp. Biol. Med., 241(7), 749–754 (2016).
   PubMed Web of Science ®Google Scholar